Castle Jeremy
SEC CIK 1992507 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| STLN | Starling Oncology, Inc. | COO | 247.0K | $9,418 | — | 6 | 2023-11-30 | 2025-05-21 |
Most active insiders at STLN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Chernett Jorey | 10% | $2.69M | — |
| 2 | Hively Brad | Dir | — | $2.00M |
| 3 | Kaushal Mohit | Dir | — | $335.1K |
| 4 | Podnos Yale | Chief Medical Off | — | $276.4K |
| 5 | Pacala Mark L | Dir | — | $200.0K |
| 6 | Carter Robert Ross | CFO | — | $879.32 |
| 7 | England Kristin | Chief Administrative Off | — | — |
| 8 | Langsam Jeffrey | Chief Clinical Off | — | — |
| 9 | Ling Gabriel | Dir | — | — |
| 10 | TOI M, LLC | Dir | — | — |
Castle Jeremy made no open-market trades at STLN in the last 12 months.
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-05-22 | 2025-05-21 | STLN | Starling Oncology, Inc. | Castle Jeremy | COO | D - Sale to Iss | $2.68 | -5,636 | 247.0K | -2% | -$15.1K | |
| 2025-04-02 | 2025-03-31 | STLN | Starling Oncology, Inc. | Castle Jeremy | COO | A - Grant | $0.00 | +162.3K | 252.7K | +180% | $0 | |
| D | 2025-03-28 | 2025-03-26 | STLN | Starling Oncology, Inc. | Castle Jeremy | COO | P - Purchase | $1.04 | +9,056 | 90.4K | +11% | +$9,418 |
| 2024-12-05 | 2024-12-03 | STLN | Starling Oncology, Inc. | Castle Jeremy | COO | D - Sale to Iss | $0.16 | -1,130 | 81.3K | -1% | -$180.80 | |
| D | 2024-05-23 | 2024-05-21 | STLN | Starling Oncology, Inc. | Castle Jeremy | COO | A - Grant | $0.00 | +70.1K | 82.5K | +568% | $0 |
| D | 2023-12-04 | 2023-11-30 | STLN | Starling Oncology, Inc. | Castle Jeremy | COO | A - Grant | $0.00 | +12.3K | 12.3K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations